Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC
{{output}}
Introduction: Blood-based next-generation sequencing assays of circulating tumor DNA (ctDNA) have the ability to detect tumor-associated mutations in patients with SCLC. We sought to characterize the relationship between ctDNA me... ...
